Jan 27th, 2023
Thursday's Late-Breaking Science
Four presentations focus on the results from a community-based intervention in acute stroke, tenecteplase vs. alteplase comparison and two trials on the Lacunar intervention.
11 a.m.-12:30 p.m., Hall E
- Increased Acute Stroke Treatment Rates in Flint, Michigan: Results From Stroke Ready: A Community Engaged Emergency Department and Community Intervention
- Tenecteplase Versus Alteplase in Acute Ischemic Cerebrovascular Events ( TRACE II): A Phase 3, Multicenter, Open-Label, Randomized Controlled, Non-Inferiority Trial
- Cilostazol, Isosorbide Mononitrate and Their Combination to Prevent Recurrence and Dependency In Patients With Small Vessel Disease Stroke: The Lacunar Intervention Trial-2 (LACI-2)
- Isosorbide Mononitrate, Cilostazol and Their Combination To Prevent Cognitive Impairment in Patients With Small Vessel Disease Stroke: The Lacunar Intervention Trial-2 (LAC-2)
